[1] 王玲.基于医院信息系统开展药品不良反应监测研究[J].中国药物警戒,2015, 12(4):229-231. [2] 陈超,郭代红,薛万国,等.住院患者药品不良事件主动监测与评估警示系统的研发[J].中国药物警戒,2013,10(7):411-414. [3] Rubin D B. Estimating causal effects of treatments in randomized and nonrandomized studies[J]. Journal of Educational Psychology, 2014, 66(1):688-701. [4] Paul W H. Satistics and Causal Inference[J]. Journal of the American Statistical Association, 1986, 81(396): 945-960. [5] 张颖,杨国彦,王禹毅,等.因果关系模型在中医药观察性研究中应用的探讨[J].现代中医临床,2014,21(5):19-22. [6] Austin P C. An introduction to propensity-score methods for reducing confounding in observational studies[M]. Multivariate Behavioral Research, 2011, 46(3): 399-424. [7] Snowden J M, Rose S, Mortimer K M. Implementation of G-computation on a simulated data set: demonstration of a causal inference technique[J]. American Journal of Epidemiology, 2011, 173(7):731-738. [8] M. J. van der Laan, Rubin D B. Targeted Maximum Likelihood Learning[J]. International Journal of Biostatistics, 2006, 2(1):1043-1043. [9] Rubin D B. Statistics and Causal Inference: Comment: Which Ifs Have Causal Answers[J]. Journal of the American Statistical Association, 1986, 81(396):961-962. [10] Greenland S, Robins J M. Identifiability, exchangeability, and epidemiological confounding[J]. International Journal of Epidemiology, 1986, 15(3):413-419. [11] Petersen M L, Porter K, Gruber S, et al. Diagnosing and responding to violations in the positivity assumption[M].Statistical Methods in Medical Research. 2010:31-54. [12] Porter K E, Gruber S, M. J. van der Laan, et al. The relative performance of targeted maximum likelihood estimators.[J]. International Journal of Biostatistics, 2010, 7(1):1-34. [13] M. J. van der Laan, Gruber S. Collaborative double robust targeted maximum likelihood estimation[J]. International Journal of Biostatistics, 2010, 6(1):391-408. [14] K. L. Moore, M. J. van der Laan. Covariate adjustment in randomized trials with binary outcomes: Targeted maximum likelihood estimation[J]. Statistics in Medicine, 2009, 28(1):39-64. [15] Rose S, M. J. van der Laan. A double robust approach to causal effects in case-control studies[J]. American Journal of Epidemiology, 2014, 179(6):663-669. [16] Stitelman O M, De G V, M. J. van der Laan. A general implementation of TMLE for longitudinal data applied to causal inference in survival analysis[J]. International Journal of Biostatistics, 2012, 8(1):207-217. [17] Rosenblum M, Mark J. van der Laan. Targeted Maximum Likelihood Estimation of the Parameter of a Marginal Structural Model[J]. International Journal of Biostatistics, 2009, 6(2):Article 19. [18] Wenjing Z, M. J. van der Laan. Targeted Maximum Likelihood Estimation of Natural Direct Effects[M]. U.C. Berkeley Division of Biostatistics Working Paper Series. 2012:1-40. [19] Schuler M S, Rose S. Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies[J]. American Journal of Epidemiology, 2017, 185(1): 65-73. [20] Pang M, Schuster T, Filion K B, et al. Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research[J]. Epidemiology, 2016, 27(4):570-577. [21] Pirracchio R, Yue J K, Manley G T, et al. Collaborative targeted maximum likelihood estimation for variable importance measure: Illustration for functional outcome prediction in mild traumatic brain injuries[J]. Statistical Methods in Medical Research, 2016. DOI: 10.1177/0962280215627335. [22] Lendle S D, Fireman B, M. J. van der Laan. Targeted maximum likelihood estimation in safety analysis[J]. Journal of Clinical Epidemiology, 2013, 66(8):91-98. [23] Gruber S, M. J. van der Laan. An application of targeted maximum likelihood estimation to the meta-analysis of safety data[J]. Biometrics, 2013, 69(1):254-262. [24] M. J. van der Laan, Rose S. Targeted Learning: Causal Inference for Observational and Experimental Data[J]. Targeted Learning Causal Inference for Observational & Experimental Data, 2011. [25] Gruber S, M. J. van der Laan. tmle : An R Package for Targeted Maximum Likelihood Estimation[J]. Journal of Causal Inference, 2012, 51(13):1161-1189. [26] Rassen J A, Schneeweiss S. Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system[J]. Pharmacoepidemiology & Drug Safety, 2012, 21 S1):41-49. [27] Gruber S, Mark J. van der Laan. A Targeted Maximum Likelihood Estimator of a Causal Effect on a Bounded Continuous Outcome[J]. International Journal of Biostatistics, 2010, 6(1):Article 26. [28] Lumley T. Network meta-analysis for indirect treatment comparisons[J]. Statistics in Medicine, 2002, 21(16):2313-2324. [29] Arbogast P G, Ray W A. Use of disease risk scores in pharmacoepidemiologic studies[J]. Statistical Methods in Medical Research, 2009, 18(1):67-80. |